|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/10 | |
| A61K 31/70 | |||
| C07K 14/00 | |||
| C07K 7/08 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2994155 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14794114.0 |
| Europos patento paraiškos padavimo data | 2014-05-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-03-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/037377 |
| Data | 2014-05-08 |
| (87) | Numeris | WO 2014/182955 |
| Data | 2014-11-13 |
| (30) | Numeris | Data | Šalis |
| 201361821028 P | 2013-05-08 | US |
| (72) |
WEIHUA, Zhang, US
|
| (73) |
The University of Houston System,
316 E. Cullen, Houston, TX 77204-2015,
US
|
| (54) | TARGETING THE EGFR-SGLT1 INTERACTION FOR CANCER THERAPY |
| TARGETING THE EGFR-SGLT1 INTERACTION FOR CANCER THERAPY |